Both in Pharmaceuticals
Kardigan vs Damora Therapeutics
Over the past year KARD returned −30.9% and DMRA returned −24.9%; their daily moves had a correlation of 0.58.
KARD −30.9% DMRA −24.9%Growth of $1, one year, split-adjusted
| Metric | KARD | DMRA |
|---|---|---|
| Price | $12.63 | $20.73 |
| Market cap | $1.18B | $1.28B |
| Today | −0.90% | −4.51% |
| 1 month | −12.3% | +2.3% |
| 6 months | — | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $597.6M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | — |
| Short % of float | 11.6% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).